[Recent therapeutic trials by intravenous route of the substances 22 Th and 4099 Th in cochleovestibular syndromes of vascular origin].
D000924:Anticholesteremic Agents; D003051:Cochlea; D015834:Cochlear Diseases; D004194:Disease; D010654:Phenylbutyrates / Q000628:therapy*; D013577:Syndrome; D015837:Vestibular Diseases; D014722:Vestibule, Labyrinth
D000924:Anticholesteremic Agents; D010654:Phenylbutyrates
CHOLESTEROL/antagonists; COCHLEA/diseases; PHENYLBUTYRATES/therapy; VESTIBULAR APPARATUS/diseases